On July 23, 2009, Hartz, Richard A.; Ahuja, Vijay T.; Arvanitis, Argyrios G.; Rafalski, Maria; Yue, Eddy W.; Denhart, Derek J.; Schmitz, William D.; Ditta, Jonathan L.; Deskus, Jeffrey A.; Brenner, Allison B.; Hobbs, Frank W.; Payne, Joseph; Lelas, Snjezana; Li, Yu-Wen; Molski, Thaddeus F.; Mattson, Gail K.; Peng, Yong; Wong, Harvey; Grace, James E.; Lentz, Kimberley A.; Qian-Cutrone, Jingfang; Zhuo, Xiaoliang; Shu, Yue-Zhong; Lodge, Nicholas J.; Zaczek, Robert; Combs, Andrew P.; Olson, Richard E.; Bronson, Joanne J.; Mattson, Ronald J.; Macor, John E. published an article.Quality Control of (S)-1-Methoxypropan-2-amine hydrochloride The title of the article was Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of N3-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists. And the article contained the following:
Evidence suggested that corticotropin-releasing factor-1 (CRF1) receptor antagonists may offer therapeutic potential for the treatment of diseases associated with elevated levels of CRF such as anxiety and depression. A pyrazinone-based chemotype of CRF1 receptor antagonists was discovered. Structure-activity relationship studies led to the identification of numerous potent analogs including I, a highly potent and selective CRF1 receptor antagonist with an IC50 value of 0.26 nM. The pharmacokinetic properties of I were assessed in rats and Cynomolgus monkeys. Compound I was efficacious in the defensive withdrawal test (an animal model of anxiety) in rats. The synthesis, structure-activity relationships and in vivo properties of compounds, e.g., I, within the pyrazinone chemotype were described. The experimental process involved the reaction of (S)-1-Methoxypropan-2-amine hydrochloride(cas: 1162054-86-5).Quality Control of (S)-1-Methoxypropan-2-amine hydrochloride
The Article related to pyrazinone arylamino asym preparation corticotropin releasing factor receptor antagonist, arylamino pyrazinone corticotropin releasing factor receptor antagonist sar activity, anxiolytic agent pyrazinone arylamino crf receptor antagonist sar activity and other aspects.Quality Control of (S)-1-Methoxypropan-2-amine hydrochloride
Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem